Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial

<i>Objectives</i>: To assess the clinical outcomes of mpMRI before biopsy and evaluate the space remaining for novel biomarkers. <i>Methods:</i> The INNOVATE study was set up to evaluate the validity of novel fluidic biomarkers in men with suspected prostate cancer who underg...

Full description

Bibliographic Details
Main Authors: Hayley Pye, Saurabh Singh, Joseph M. Norris, Lina M. Carmona Echeverria, Vasilis Stavrinides, Alistair Grey, Eoin Dinneen, Elly Pilavachi, Joey Clemente, Susan Heavey, Urszula Stopka-Farooqui, Benjamin S. Simpson, Elisenda Bonet-Carne, Dominic Patel, Peter Barker, Keith Burling, Nicola Stevens, Tony Ng, Eleftheria Panagiotaki, David Hawkes, Daniel C. Alexander, Manuel Rodriguez-Justo, Aiman Haider, Alex Freeman, Alex Kirkham, David Atkinson, Clare Allen, Greg Shaw, Teresita Beeston, Mrishta Brizmohun Appayya, Arash Latifoltojar, Edward W. Johnston, Mark Emberton, Caroline M. Moore, Hashim U. Ahmed, Shonit Punwani, Hayley C. Whitaker
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
biomarkers
INNOVATE
multiparametric MRI
prostate cancer
diagnosis
PSA density
Online Access:https://www.mdpi.com/2072-6694/13/8/1985

Internet

https://www.mdpi.com/2072-6694/13/8/1985

Similar Items